Status:
COMPLETED
Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor
Lead Sponsor:
Dilafor AB
Conditions:
Pregnancy
Labor
Eligibility:
FEMALE
18-40 years
Phase:
PHASE2
Brief Summary
The study is a Proof-of-concept study to evaluate if DF01 can prevent protracted labor. Time to delivery will be measured from the time of at least 3 cm cervix dilatation and 3 contractions of minimum...
Eligibility Criteria
Inclusion
- healthy nulliparous females
- normal singleton pregnancy
- intact membranes
Exclusion
- breech or other abnormal presentation
- intercurrent illness
- pregnancy complications
- vaginal bleeding in third trimester
- etc
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
263 Patients enrolled
Trial Details
Trial ID
NCT00710242
Start Date
April 1 2007
End Date
May 1 2009
Last Update
May 19 2009
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Kvinnokliniken Alvsborgs sjukhus Boras
Borås, Sweden, SE-501 82
2
Gavle sjukhus
Gävle, Sweden
3
Sahlgrenska/Ostra sjukhuset
Gothenburg, Sweden
4
Karolinska Universistetssjuhuset
Huddinge, Sweden